Sylvain Feliciangeli

Birk-Barel syndrome (BBS), also known as KCNK9 imprinting syndrome, is a neurodevelopmental disorder caused by mutations in the maternally expressed paternally imprinted KCNK9 gene that encodes the TASK3 potassium channel. The first mutation identified in patients with BBS was a loss-of-function variant that reduces the potassium current mediated by TASK3. Subsequent studies have uncovered additional pathogenic variants, including gain-of-function mutations, that increase TASK3 activity. Here, we show that both mutations resulted in the expression of the hyperactive Task3M159I variant or the hypoactive Task3G236R variant, which caused early postnatal lethality in mice when maternally inherited, confirming the monogenic nature of BBS. These results indicate that the pathogenesis of BBS involves mechanisms other than alterations in channel activity. Consequently, the proposed therapeutic strategies, such as pharmacological modulation of the TASK3 channel function or epigenetic reactivation of the paternal KCNK9 allele, do not seem to be viable options. These findings also demonstrate that TASK3 knockout mice are not suitable models for studying KCNK9 imprinting syndrome or for developing therapies for affected patients. Therefore, there is an urgent need for animal models that allow conditional expression of BBS-associated mutations.

Two-pore domain potassium channels (K _2P ) regulate neuronal excitability by acting as hyperpolarizing leak channels. Among them, THIK2 remain poorly characterized. Although no study has yet clearly linked them to excitability or pain, their selective expression in nociceptive neurons of the Dorsal Root Ganglia (DRG) suggests a role in nociception and pain regulation. This project investigates THIK2 channels in pain pathophysiology through molecular, electrophysiological, and behavioral approaches. We mapped THIK expression patterns and in THIK2 knock-out mice, we examined DRG neuron excitability and pain sensitivity. Results reveal thermal hypersensitivity under both naive and inflammatory conditions, indicating that THIK2 normally limits neuronal hyperexcitability. These findings position THIK2 as a potential therapeutic target in chronic inflammatory pain, with peripheral inhibition potentially offering analgesia without central opioid side effects.

At neutral pH, the TWIK1 channel is highly selective for K ⁺ . When exposed to acidification, it becomes permeable to Na ⁺ . This change occurs within minutes and is reversible. By combining pKa calculations, molecular dynamics (MD) simulations, mutagenesis and electrophysiology, we identified a network of residues involved in this unique property. MD simulations captured crucial features associated with channel gating and previously observed by cryogenic electron microscopy (cryo-EM) at pH7.4 and pH5, such as the pH-dependent orientation of the lateral side chain of the proton sensor His122 and the elongation of the entire pore structure upon acidification. Between the closed and open states of TWIK1 observed by cryo-EM, MD simulations show that the channel undergoes additional conformational changes between pH 7.5 to 6 that involves the His122, Glu235, Lys246 and Phe109 residues. A complex network of interactions surrounding the selectivity filter at high pH transforms into a simple set of stronger interactions at low pH. In particular, His122 protonated by acidification moves away from Lys246 and engages in a salt bridge with Glu235. In addition, stacking interactions between Phe109 and His122, which stabilize the selectivity filter in its K ⁺ -selective state at high pH, disappear upon acidification. This causes dissociation of the Phe109 aromatic side chain from this network, ultimately leading to the Na ⁺ -permeable conformation of the channel.

Two-pore domain (K _2P ) potassium channels are active as dimers. They produce inhibitory currents regulated by a variety of stimuli. Among them, TALK1, TALK2 and TASK2 form a subfamily of structurally related K _2P channels stimulated by extracellular alkalosis. The human genes encoding them are clustered on chromosomal region 6p21. They are expressed in different tissues including the pancreas. By analyzing single cell transcriptomic data, we show that these channels are co-expressed in insulin-secreting pancreatic β cells. By different approaches we show that they form functional heterodimers. Heteromerization of TALK2 with TALK1 or with TASK2 endorses TALK2 with sensitivity to extracellular alkalosis in the physiological range. The association of TASK2 with TALK1 and TALK2 increases their unitary conductance. These results provide a new example of heteromerization in the K _2P channel family expanding the range of their potential physiological and pathophysiological roles.

Inhibitory potassium channels of the TREK1/TRAAK family are integrators of multiple stimuli, including temperature, membrane stretch, polyunsaturated fatty acids and pH. How these signals affect the gating of these channels is the subject of intense research. We have previously identified a cytoplasmic domain, pCt, which plays a major role in controlling channel activity. Here, we use pharmacology to show that the effects of pCt, arachidonic acid, and extracellular pH converge to the same gate within the channel. Using a state-dependent inhibitor, fluoxetine, as well as natural and synthetic openers, we provide further evidence that the “up” and “down” conformations identified by crystallography do not correspond to open and closed states of these channels.

TREK/TRAAK channels are polymodal K⁺ channels that convert very diverse stimuli, including bioactive lipids, mechanical stretch and temperature, into electrical signals. The nature of the structural changes that regulate their activity remains an open question. Here, we show that a cytoplasmic domain (the proximal C-ter domain, pCt) exerts antagonistic effects in TREK1 and TRAAK. In basal conditions, pCt favors activity in TREK1 whereas it impairs TRAAK activity. Using the conformation-dependent binding of fluoxetine, we show that TREK1 and TRAAK conformations at rest are different, and under the influence of pCt. Finally, we show that depleting PIP₂ in live cells has a more pronounced inhibitory effect on TREK1 than on TRAAK. This differential regulation of TREK1 and TRAAK is related to a previously unrecognized PIP₂-binding site (R329, R330, and R331) present within TREK1 pCt, but not in TRAAK pCt. Collectively, these new data point out pCt as a major regulatory domain of these channels and suggest that the binding of PIP₂ to the pCt of TREK1 results in the stabilization of the conductive conformation in basal conditions.

Recombinant TWIK2 channels produce weak basal background K⁺ currents. Current amplitudes depend on the animal species the channels have been isolated from and on the heterologous system used for their re-expression. Here we show that this variability is due to a unique cellular trafficking. We identified three different sequence signals responsible for the preferential expression of TWIK2 in the Lamp1-positive lysosomal compartment. Sequential inactivation of tyrosine-based (Y₃₀₈ASIP) and di-leucine-like (E₂₆₆LILL and D₂₈₂EDDQVDIL) trafficking motifs progressively abolishes the targeting of TWIK2 to lysosomes, and promotes its functional relocation at the plasma membrane. In addition, TWIK2 contains two N-glycosylation sites (N₇₉AS and N₈₅AS) on its luminal side, and glycosylation is necessary for expression in lysosomes. As shown by electrophysiology and electron microscopy, TWIK2 produces functional background K⁺ currents in the endolysosomes, and its expression affects the number and mean size of the lysosomes. These results show that TWIK2 is expressed in lysosomes, further expanding the registry of ion channels expressed in these organelles.

Potassium channels participate in many biological functions, from ion homeostasis to generation and modulation of the electrical membrane potential. They are involved in a large variety of diseases. In the human genome, 15 genes code for K⁺channels with two pore domains (K_2P). These channels form dimers of pore‐forming subunits that produce background conductances finely regulated by a range of natural and chemical effectors, including signalling lipids, temperature, pressure, pH, antidepressants and volatile anaesthetics. Since the cloning of TWIK1, the prototypical member of this family, a lot of work has been carried out on their structure and biology. These studies are still in progress, but data gathered so far show that K_2Pchannels are central players in many processes, including ion homeostasis, hormone secretion, cell development and excitability. A growing number of studies underline their implication in physiopathological mechanisms, such as vascular and pulmonary hypertension, cardiac arrhythmias, nociception, neuroprotection and depression. This review gives a synthetic view of the most noticeable features of these channels.